Erythropoietin for the Repair of Cerebral Injury in Very Preterm Infants

NCT02076373 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Intraventricular Hemorrhage of Prematurity

Interventions

DRUG: recombinant human Erythropoietin
DRUG: Placebo

Sponsor

University of Zurich

Collaborators

[object Object]